[1] | Ru JIA, Pingping ZHANG, Yuan YUAN, Yiyang HU, Qin FENG. Differences and application value of plasma bile acids in tumors of the liver[J]. Journal of Clinical Hepatology, 2024, 40(10): 2042-2048. doi: 10.12449/JCH241018 |
[2] | WANG WenHui, DUAN XuHua, LI Hao, LI FengYao, JU ShuGuang, WANG ManZhou, REN JianZhuang, HAN XinWei. Effect of arsenic trioxide-loaded CalliSpheres beads in the treatment of rabbits with VX2 liver tumor[J]. Journal of Clinical Hepatology, 2020, 36(12): 2730-2734. doi: 10.3969/j.issn.1001-5256.2020.12.018 |
[3] | ZHANG ZhongLin, YUAN YuFeng. Key operating points of laparoscopic hepatectomy for liver tumor in difficult locations[J]. Journal of Clinical Hepatology, 2020, 36(12): 2663-2666. doi: 10.3969/j.issn.1001-5256.2020.12.006 |
[4] | Li ShanShan, Zhang Ke, Cheng ShuJie, Yang JiHong, Gao Feng, Li JingHua. Current status and future perspectives of the application of medical 3D visualization technology in accurate surgery of liver tumors[J]. Journal of Clinical Hepatology, 2019, 35(5): 1114-1117. doi: 10.3969/j.issn.1001-5256.2019.05.042 |
[5] | Wang ZhiYu, Gu SanWei, Chen XiaoQian, Cai YanJun. Clonorchiasis misdiagnosed as hepatic tumor: a case report[J]. Journal of Clinical Hepatology, 2018, 34(3): 602-603. doi: 10.3969/j.issn.1001-5256.2018.03.033 |
[6] | An DongJun, An Lin, Zhang Cheng, Zhao WeiAn, Han Li. Efficacy of laparoscopic microwave ablation in treatment of malignant liver tumors[J]. Journal of Clinical Hepatology, 2017, 33(11): 2158-2161. doi: 10.3969/j.issn.1001-5256.2017.11.021 |
[7] | Lu NingNing, Sun Bin, Cui XiongWei, Long Jiang, Gao WenFeng, Zheng JiaSheng. Diagnosis and treatment of subcapsular hemorrhage after liver tumor ablation[J]. Journal of Clinical Hepatology, 2017, 33(12): 2326-2330. doi: 10.3969/j.issn.1001-5256.2017.12.014 |
[8] | Yu Tong, Zhai XiaoFeng, Liu Qun, Meng YongBin, Lu JianYing, Chen Zhe. Clinical effect and safety of hepatic arterial infusion of cinobufotalin injection combined with lipiodol chemoembolization in treatment of Barcelona Clinic Liver Cancer stage C primary liver cancer[J]. Journal of Clinical Hepatology, 2017, 33(2): 281-285. doi: 10.3969/j.issn.1001-5256.2017.02.015 |
[9] | Hao MingZhi, Lin HaiLan, Chen QiZhong, Hu YuBin. Effect of recombinant human endostatin combined with hepatic artery interventional therapy on progression-free survival of patients with advanced hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(1): 92-96. doi: 10.3969/j.issn.1001-5256.2016.01.016 |
[10] | Liu Qi, Wu ZhenMing, Qi XiuHeng, Guo Qian. Survival analysis of intrahepatic arterial infusion of Endostar combined with transcatheter arterial chemoembolization for treatment of advanced hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(2): 225-227. doi: 10.3969/j.issn.1001-5256.2015.02.019 |
[11] | Zhang YuHuan, Jian ZhiYuan, Gao Yi, Zhu YanZhi. Prognostic impact of portal vein immunochemotherapy in patients after resection of primary hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(11): 1186-1189. doi: 10.3969/j.issn.1001-5256.2014.11.024 |
[12] | Nie Lei, Wu DongDe, Zhang Feng, Xia XiaoQin. Application of chemosensitivity test in regional chemotherapy for hepatocellular carcinoma via hepatic artery and portal vein[J]. Journal of Clinical Hepatology, 2013, 29(8): 616-619. doi: 10.3969/j.issn.1001-5256.2013.08.016 |
[13] | Chen MinHua. Standardization of thermal ablation in treatment of liver tumor[J]. Journal of Clinical Hepatology, 2013, 29(8): 561-563. doi: 10.3969/j.issn.1001-5256.2013.08.001 |
[14] | Wang JiPing, Leng JiYan, Cui YaQiong, Zhang Li, Wang Yan. The diagnosis and clinical value of multi-slice spiral CT in children with common liver tumor[J]. Journal of Clinical Hepatology, 2011, 27(7): 718-721. |
[15] | Chen Hong, Wang Zhi, Wu Jian. Circulating tumor cells of hepatocellular carcinoma and their clinical implications[J]. Journal of Clinical Hepatology, 2011, 27(8): 796-800. |
[17] | Yang BiWei, Gan YuHong, Ye ShengLong, Zhang BoHeng, Ren ZhengGang, Xia JingLin, Wang YanHong, Ge NingLing, Chen Yi, Li LiXin, Le Fan, Zhang Lan. Necrosis range and safety of radiofrequency combined with systemic chemotherapy and radiofrequency alone.[J]. Journal of Clinical Hepatology, 2004, 20(6): 364-365. |